Disease + strategy intelligence
Frame the opportunity, assumptions, scenarios, and material uncertainties.
APPLICATIONS
Start with the decision. Then choose the scope.
Country strategy, protocol feasibility, site priorities, or competitive change: focus the engagement on the question that could change your next commitment.
Start with the decision that is material now.
A focused scope can expand only after the first signal proves useful.
Synthetic example
A recommendation is only as useful as the reasoning behind it.
Choose a question. Inspect a candidate. See what supports the next step—and what could change it.
Country strategy
Which market deserves a closer look?
Testing access and startup assumptions remain unverified.
Explore a decision ↗Cohort feasibilityDoes the patient hypothesis hold up?
Testing completion and protocol eligibility are unknown.
Explore a decision ↗Site prioritizationWhich site should enter feasibility first?
Team capacity and activation timing remain unknown.
Explore a decision ↗
The evidence trail evolves with the program instead of restarting at each gate.
Trial + site + PI + patient intelligence
Turn protocol context into a prioritized diligence plan.
Enrollment risk + changing competition
Update the evidence as operational reality and the competitive landscape change.
Continuous intelligence
Preserve the evidence and review history across related decisions.
A first pilot is scoped around one asset or protocol, one material decision, one geography or cohort, and pre-agreed success criteria.
START WITH ONE DECISION
A focused pilot begins with a fixed question.
The first engagement is designed to produce an independent signal that can be compared with the sponsor's or CRO's current view.
Outputs are for strategic planning and do not guarantee patient availability, enrollment, site performance, regulatory outcomes, or clinical success.